BORTHWICK KATHLEEN (SVP, Interim CFO) sold 4.9% of their position (1.47K shares) of PASSAGE BIO, INC. on the open market
Open‑market sale worth $1.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/13/2024ACC: 0001415889-24-003640
Officer· SVP, Interim CFO
Since Jul 2023
-1.47K
Net shares
Net seller
$1.4K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
4K acquired · 5.47K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+4K
Price / share
—
Trade value
—
% of position
15.4%
2/10/2024
25.94K→29.94K
Common Stock
Direct
Shares
−1.47K
Price / share
$0.97
Trade value
$1.43K
% of position
4.9%
2/13/2024
29.94K→28.47K
Total
Net shares
+2.53K
Net value
-$1.43K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/10/2024 | M · Option Exercise | +4K | — | — | 15.4% | 25.94K | 29.94K |
| Common Stock Direct | 2/13/2024 | S · Sale | −1.47K | $0.97 | $1.43K | 4.9% | 29.94K | 28.47K |
| Total | +2.53K | -$1.43K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
4K shares
Shares
−4K
Strike price
Held after
8K
Exercisable
—
2/10/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock4K shares | 2/10/2024 | M · Option Exercise | −4K | — | 8K |